分子生物学酶、试剂盒和试剂市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按产品(酶、试剂盒和试剂)、应用、最终用户和地理划分

市场快照

Molecular Biology Enzymes kits And Reagents Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.5 %
Molecular Biology Enzymes kits And Reagents Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

研发(R&D)被定义为创造新产品、工艺和技术的过程,这些新产品、工艺和技术可以在未来为人类的利益而使用和销售。亚洲尤其是中国的研发投资增加,以及北美研发支出的连续年度增长表明,整个工业部门都处于稳定、安全和良性竞争的时期。根据 2019 年全球研发资金预测,由 Advantage Business Marketing 出版的 R&D 杂志发布的年度研究显示,2019 年全球研发投入增长约 3.6%,达到 2.3 万亿美元,以购买力平价(PPP ) 对 110 多个国家进行重大研发投资(超过 1 亿美元)的价值。因此,增加了研究和研发

此外,技术进步以及传染病和遗传疾病发病率的上升是刺激市场增长的一些因素。

报告范围

根据报告的范围,分子生物学酶、试剂盒和试剂用于分析作为诊断和/或治疗靶点的细胞表面标志物。分子生物学酶是生物体(动物、植物和细菌)产生的天然蛋白质,是高选择性的生化催化剂。分子生物学试剂是分子生物学反应中用于优化工作流程的化学品。

By Product
Enzymes
Kits and Reagents
By Application
Polymerase Chain Reaction
Sequencing
Epigenetics
Other Applications
By End Users
Hospitals and Diagnostic Centers
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

聚合酶链式反应部分预计将在预测年份显示出更好的增长

根据应用程序,它分为聚合酶链反应(PCR)、测序、表观遗传学和其他应用程序。该细分市场的增长主要归因于遗传病、传染病和慢性病的患病率增加。基于 PCR 的检测越来越多地用于指导患者管理,特别是在传染病、癌症和先天性异常领域。据世界卫生组织称,癌症是全球第二大死因,2018 年估计有 960 万人死亡。PCR 技术通常用于肿瘤分析和细菌感染检测。由于 PCR 在分子生物学领域的广泛应用,预计该细分市场在预测期内将呈现出较好的增长势头。

Molecular Biology Enzymes kits And Reagents Market Trends

北美有望主导市场

由于遗传和慢性疾病(如癌症)的日益流行以及政府的积极举措,分子生物学酶、试剂盒和试剂市场在北美地区占据主导地位。根据美国癌症协会的数据,2018 年美国新诊断出约 1,735,350 例癌症病例,同年约有 609,640 人死亡。此外,老年人口的增长以及该地区不断增长的研发活动预计将在预测期内推动市场发展。

Molecular Biology Enzymes kits And Reagents Market Growth

竞争格局

进入分子生物学酶、试剂盒和试剂市场的全球参与者包括 Agilent Technologies, Inc.、F.Hoffmann-La Roche Ltd.、Illumina, Inc.、Lucigen Corporation、Merck KGaA、New England Biolabs、Promega Corporation、Qiagen NV 、宝生物公司和赛默飞世尔科技。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders

      2. 4.2.2 Increasing R&D Activities in the Life Science Industry

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost and Limited Reimbursements for Genetic Testing

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Enzymes

      2. 5.1.2 Kits and Reagents

    2. 5.2 By Application

      1. 5.2.1 Polymerase Chain Reaction

      2. 5.2.2 Sequencing

      3. 5.2.3 Epigenetics

      4. 5.2.4 Other Applications

    3. 5.3 By End Users

      1. 5.3.1 Hospitals and Diagnostic Centers

      2. 5.3.2 Academic and Research Institutes

      3. 5.3.3 Pharmaceutical and Biotechnology Companies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies

      2. 6.1.2 F. Hoffmann-La Roche Ltd

      3. 6.1.3 Illumina Inc.

      4. 6.1.4 Lucigen Corporation

      5. 6.1.5 Merck KGaA

      6. 6.1.6 New England Biolabs

      7. 6.1.7 Promega Corporation

      8. 6.1.8 Qiagen NV

      9. 6.1.9 Takara Bio Inc.

      10. 6.1.10 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Molecular Biology Enzymes, Kits and Reagents Market market is studied from 2018 - 2026.

The Molecular Biology Enzymes, Kits and Reagents Market is growing at a CAGR of 10.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Agilent Technologies, F. Hoffmann-La Roche Ltd, Merck KGaA, Qiagen NV, Thermo Fisher Scientific are the major companies operating in Molecular Biology Enzymes, Kits and Reagents Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!